Biphasic human insulin 30 thrice daily, is it reasonable?

To evaluate the efficacy and safety of thrice daily Biphasic Human Insulin 30 (BHI 30) versus the traditional twice-daily regimen in type 2 diabetes mellitus (T2DM) patients. It ’s a cross over single clinical ...

Source: BMC Research Notes - May 24, 2020 Category: Research Authors: Nesreen A. Saadeh, Ola Y. Al-Azzeh and Yousef S. Khader Tags: Research note Source Type: research